Scotiabank upgraded Beam Therapeutics (BEAM) to Outperform from Sector Perform with a $40 price target Optimize Your Investment Research with ...

Beam Therapeutics shares were 14% lower, at $24.60, after the company priced an underwritten offering with proceeds of $500 million. The biotechnology company said it is offering 16.2 million shares ...

H.C. Wainwright analyst Patrick Trucchio reiterates a Buy rating and $80 price target on Beam Therapeutics (BEAM) shares after the company ...

Take these mental health quotes, for example, which are powerful tools for shifting your mindset and motivating you to push forward. Of course, if you are going through a particularly hard time in ...

Once submitted, we will try and place you in contact with a suitable Split-Beam Spectrophotometers supplier within 48 hours.

Please purchase a Premium Subscription to continue reading. To continue, please log in, or sign up for a new account. We offer one free story view per month. If you ...

Our calculations are based on comprehensive, delayed quotes. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all ...

Please purchase a Premium Subscription to continue reading. To continue, please log in, or sign up for a new account. We offer one free story view per month. If you ...